

![]() |
Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients |
|
Authors | ![]() | |
Published in | Clinical transplantation. 2011, vol. 25, no. 4, p. 660-9 | |
Abstract | The aim of this study was to evaluate the tolerability of the conversion from calcineurin inhibitor (CNI) to everolimus (ERL) in maintenance liver transplant (LT) recipients. | |
Keywords | Calcineurin/antagonists & inhibitors — Cohort Studies — Cyclosporine/therapeutic use — Female — Follow-Up Studies — Graft Rejection/drug therapy — Graft Survival — Humans — Immune Tolerance/drug effects — Immunosuppressive Agents/therapeutic use — Liver Transplantation — Male — Middle Aged — Sirolimus/analogs & derivatives/therapeutic use — Survival Rate — Tacrolimus/therapeutic use — Treatment Outcome | |
Identifiers | PMID: 21158921 | |
Full text | ||
Structures | ||
Research group | Hépatologie chirurgicale (327) | |
Citation (ISO format) | VALLIN, Mélanie et al. Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients. In: Clinical transplantation, 2011, vol. 25, n° 4, p. 660-9. doi: 10.1111/j.1399-0012.2010.01370.x https://archive-ouverte.unige.ch/unige:25232 |